Search Results

You are looking at 1 - 10 of 13 items for :

  • pharmacokinetics x
  • General Interest x
Clear All
Open access

Antoņina Sondore, Sanita Ūdre, Jānis Nemme, Laimdota Grašiņa, Ieva Kruževņaka, Inta Matulēna, Vija Rozīte, Līga Mitre, Ivonna Vītola, Danuta Viskante, Juris Aprups, Anita Berga, Juris Bormotovs and Indulis Kokars

of Renal Transplantation (pp. 87-100) . New York, Heidelberg, Berlin: Springer-Verlag. de Gasperi, A., Mazza, E., Noe, L., Corti, A., Cristalli, A., Prosperi, M., Sabbadini, D., Savi, M. C., Vai, S. (1996). Pharmacokinetic profile of the induction dose of propofol in chronic renal failure patients undergoig renal transplantation. Minerva Anaesthesiol ., 62 , 25-31. Eger, E., 2nd, Koblin, D. D., Bowland, T., Ionescu, P., Laster, M.J., Fang, Z., Gong, D., Sonner, J., Weiskopf, R. B. (1977). Nephrotoxicity of sevoflurane versus

Open access

Aleksandra Aitullina, Angelika Krūmiņa, Vinita Cauce and Santa Purviņa

., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., Nation, R. L. (2011). Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother ., 55 (7), 3284–3294. Gauthier, T. P., Wolowich, W. R., Reddy, A., Cano, E., Abbo, L., Smith, L. B. (2012). Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients

Open access

Aldis Strēlnieks, Alberts Bērziņš, Māra Karakone, Irina Pupkeviča, Kristīne Jubele, Maija Vikmane, Sandis Sakne, Oskars Kalējs and Aivars Lejnieks

and pharmacokinetics of rivaroxaban. Int. J. Clin. Pharmacol. Ther ., 51 (7), 549–561. Stewart, S., Murphy, N., Walker, A., McGuire, A., McMurray, J. J. V. (2004). Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart , 90 , 286–292 Strēlnieks, A., Vīnkalna, I., Lituņenko, O., Pupkevica, I., Šime, I., Vikmane, M., Kovaļova, M., Rancāne, M., Dormidontova, G., Sakne, S., Pudulis, J., Mintāle, I., Kalējs, O., Lejnieks, A. (2014). Atrial fibrillation and risk factors of recurrent paroxysms after electrical

Open access

Uldis Bērziņš, Ilze Matise-VanHoutana, Ilze Pētersone, Ilmārs Dūrītis, Sergejs Ņikuļšins, Ance Bogdanova-Jātniece, Mārtiņš Kālis, Šimons Svirskis, Dace Skrastiņa, Agnese Ezerta and Tatjana Kozlovska

. G., Kassem, M. (2005). Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem. Biophys. Res. Comm., 330 , 633–640. Blythe, L. L., Craig, A. M., Christensen, J. M., Appell, L. H., Slizeski, M. L. (1986). Pharmacokinetic disposition of dimethyl sulfoxide administered intravenously to horses. Amer. J. Vet. Res., 47 , 1739–1743. Bogdanova, A., Berzins, U., Nikulshin, S., Skrastina, D., Ezerta, A., Legzdina, D., Kozlovska, T. (2014). Characterization of human adipose

Open access

L Müller and W Röper

-361. 14. Tarka, S.M., R.B. Morrisey, J.L. Apgar, K.A. Hostetler, and CA. Shively: Chronić toxi-city/carcinogenicity studies of cocoa powder in rats; Food Chem. Toxicol. 29 (1991) 7-19. 15. British American Tobacco: The determination of theobromine added to cigarette tobacco and smoke; Internal R&D Report No. L470, 1974. 16. Simons, F.E.R, A.B. Becker, K.J. Simons, and CA. Gillespie: The bronchodilator effect and pharmaco-kinetics of theobromine in young patients with asthma; J. Allergy Clin. Immunol. 76 (1985) 703

Open access

M Dixon, K Lambing and JI Seeman

. Jacob III: Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations; in: Progress in brain research, Vol. 79, edited by A. Nordberg, K. Fuse, B. Holmstedt, and A. Sundwall, Elsevier Science Publishers, B.V., 1989, pp. 279-287. 63. Schievelbein, H.: Nicotine, resorption and fate; Pharmacol. Ther. 18 (1982) 233-248. 64. Slade, J.: Nicotine delivery devices; in: Nicotine addiction: principles and management, Vol. 4; edited by C.T. Orleans and J. Slade, Oxford University Press

Open access

AR Tricker

. Med. 44 (2002) 503–509. 17. Seccareccia, F., P. Zuccaro, R. Pacifici, P. Meli, F. Pannozzo, K.M. Freeman, A. Santaquilani, S. Giam-paoli: Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: The experience of the MATISS project; Eur. J. Epide-miol. 18 (2003) 487–492. 18. Palmer, K.J., M.M. Buckley, and D. Faulds: Transdermal nicotine: A review of its pharmacodyna-mic and pharmacokinetic properties and therapeutic efficacy as an aid to smoking cessation. Drugs 44 (1992) 498

Open access

Gerhard Scherer

. Jacob III, Elsevier, Amsterdam, The Netherlands, 1999, pp 669-719. 37. Curvall, M., CE. Elwin, E. Kazemi-Vala, C. War-holm, and CR. Enzell: The Pharmacokinetics of Cotinine in Plasma and Saliva from Non-Smoking Healthy Volunteers; Eur. J. Clin. Pharmacol. 38 (1990) 281-287. 38. Jarvis, M. J., P. Primatesta, B. Erens, C. Feyerabend, and A. Bryant: Measuring Nicotine Intake in Population Surveys: Comparability of Saliva Cotinine and Plasma Cotinine Estimates; Nicotine Tob. Res. 5 (2003) 349-355. 39. Michalke, B., B. Rossbach, T. Göen, A. Schäfer-henrich, and G

Open access

E Roemer, S Wittke, E TrellesSticken, JJ Piade, T Bonk and MK Schorp

650270002/2002, The contribution of cocoa additive to cigarette smoking addiction; RIVM, Bilthoven, Netherlands, 2003. 42. Simons, F. E. R, A. B. Becker, K. J. Simons, and CA. Gillespie: The bronchodilator effect and pharmaco-kinetics of theobromine in young patients with asthma; J. Allergy Clin. Immunol. 76 (1985) 703-707. 43. IARC, International agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 51. Coffee, Tea, Mate, Methylxanthines and Methylglyoxal; IARC, Lyon

Open access

JH Lauterbach

. 25 (1986)1181-1184. 99. Benowitz, N.L.: Pharmacokinetics and pharmaco-dynamics of nicotine; in: The pharmacology of nicotine, edited by M.J. Rand and K. Thurau, ICSU Symposium Series, Vol. 9, IRL Press Limited, McLean, VA, 1998,3-18.